NEW YORK - IN8bio, Inc. (NASDAQ:INAB), a biopharmaceutical company specializing in gamma-delta T cell therapies, reported ...

All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...

Phi Gamma Delta is now prohibited from participating in activities such as recruitment, socials and meetings as the ...

UCF's Phi Gamma Delta is suspended amid an investigation into alleged use of antisemitic symbols during hazing.

China Emerging Key Player in Development Of Gamma Delta T Cell Cancer Therapy Says KUICK RESEARCHDelhi, Jan. 29, 2025 (GLOBE ...

University of Central Florida Fraternity Banned Due to Hazing Involving Nazi Swastika, Phi Gamma Delta, UCF, antisemitism ...

PLC (NASDAQ: TCBP), a biotechnology firm with a market capitalization of $33.08 million engaged in developing gamma-delta T cell therapies, announced today significant progress in its ACHIEVE Phase 2B ...

The FDA has granted Fast Track designation to ADI-001 for the treatment of refractory systemic lupus erythematosus with extrarenal involvement.

Delta Kappa Gamma Society for Women Educators will meet at 6 p.m. Feb. 18 at First Presbyterian Church, 301 N. Walnut St., ...

IN8bio (INAB) announced new clinical data from the ongoing Phase 1 investigator-sponsored trial of INB-100, an allogeneic gamma-delta T cell ...